Centre Sanctions Funds From PMCares For Setting Up Vaccine-Testing Lab In Hyderabad

New Delhi : The Centre has sanctioned funds from the PMCares Fund for setting up a vaccine-testing laboratory here, Union Minister of State for Home G Kishan Reddy said on Saturday.

“I thank Hon’ble PM Shri Narendra Modi Ji for sanctioning funds for setting up of Vaccine Testing Lab at Hyderabad. A big step forward towards comprehensive development of pharma sector in Hyderabad, which will also boost production of Covid-9 vaccines,” Reddy, a Lok Sabha member from Secunderabad, tweeted.

The increased focus on vaccine production against the backdrop of the Covid-19 pandemic has necessitated more vaccine-testing laboratories in the country, Reddy said in a press release.

“At present, there are two vaccine-testing laboratories in the country — the Central Drug Laboratory at Kasauli and National Institute of Biologicals at Noida,” he said.

Funds have been released from the PM CARES Fund on March 6 for establishing two more such laboratories — one at National Centre for Cell Science, Pune, and the other at the National Institute of Animal Biotechnology, Hyderabad, under the Department of Biotechnology, he said.

The laboratory in Hyderabad is expected to commence operations in the next one month, he said. The setting up of the new laboratory is a big step towards the comprehensive development of the pharma sector in Hyderabad as the city is home to many pharma majors, Covid-19 vaccine production companies, and other R & D institutions, he said. It would also boost the production of Covid-19 vaccines, Reddy said.

  • Related Posts

    WHO launches new primary health care course to strengthen health systems globally

    Health is a human right – yet not everyone can access the health services they need, when and where they need them, without financial hardship. Primary health care (PHC) provides…

    Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

    Bengaluru: The Central Council for Research in Ayurvedic Sciences (CCRAS) has called for stronger scientific evidence, safety monitoring and translation of research into market-ready technologies to improve the credibility and…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    WHO launches new primary health care course to strengthen health systems globally

    WHO launches new primary health care course to strengthen health systems globally

    Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

    Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

    US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

    Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

    Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert